New & Noteworthy

Dec 11, 2017
Pharmaceutical Executive
Groundbreaking treatment approaches call for innovative commercialization strategies.
Dec 10, 2017
Pharmaceutical Executive
Drawing from his research roots and the leadership lessons gained in melding business and culture in geographies across the globe, Ruud Dobber is busy steering AstraZeneca’s US course as it navigates the complexities of a fast-evolving therapeutic market.
Dec 05, 2017
Pharmaceutical Executive
Innovation by itself won't solve the complex multichannel challenges pharmas face. Jeff Greene reports.
Nov 30, 2017
Paul Meade and Mark Schoeman describe the determining factor driving effective relationships between medical science liaisons and key opinion leaders.
Nov 30, 2017
Mark Bouch, Stephen Bungay, and David Roblin outline how the technique of "mission command", a military approach to setting direction and executing strategy in the pharmaceutical industry, has developed over the last ten years.
Nov 30, 2017
Pharmaceutical Executive
Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods.
Nov 27, 2017
Halfway through the process for establishing a national electronic drug tracking system, there’s concern among pharma companies, distributors, and pharmacists about meeting the 2023 deadline
Nov 20, 2017
While the GAIN Act's Qualified Infectious Disease Product (QIDP) designation program has been successful in driving innovation, commercial viability remains a question.
Nov 20, 2017
Abigail Bernardi explains how a better understanding of connections among practitioners on care teams helps sales reps build relationships while benefitting a company’s marketing efforts.
Nov 13, 2017
Pharmaceutical Executive
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups.
native1_300x100
lorem ipsum